argenx NV ADR
Biotechnology
Healthcare
ARGX
61.20 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
736.81
52 week high
768.00
high
742.07
52 week low
0.00
low
733.03
growth
37.78 %
previous Close
740.03
P/E ratio
225
market cap
41.66 B
div yield
0
usd
Jun 2025
qoq
revenue
948 M
19.89 %
net incoming
245 M
44.78 %
eps
3.26 %
43.29 %
eps surprise
429.01 %
net profit margin
25.88 %
4.00 %
operating incoming
204 M
46.71 %
net change in cash
0.00 %
cash on hand
2.09 B
0.00 %
cost of revenue
111 M
37.05 %
top top